|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 托伐普坦(一种口服的血管加压素拮抗剂)对心力衰竭住院患者的短期临床作用:EVEREST临床状况试验 | Gheorghiade M. Konstam M.A. Burnett Jr. J.C. 杜媛 | 2007 | 世界核心医学期刊文摘(心脏病学分册)2007，0，8： | 5 |
| 2 | 口服托伐普坦对心力衰竭恶化住院患者的效果:EVEREST预后试验 | Konstam M.A. Gheorghiade M. Burnett Jr. J.C. 杜媛 | 2007 | 世界核心医学期刊文摘(心脏病学分册)2007，0，8： | 2 |
| 3 | 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines显示文摘 | Mariell Jessup William T. Abraham Donald E. Casey Arthur M. Feldman Gary S. Francis Theodore G. Ganiats Marvin A. Konstam Donna M. Mancini Peter S. Rahko Marc A. Silver Lynne Warner Stevenson Clyde W. Yancy Sharon Ann Hunt William T. Abraham Marshall H. C | 2009 | Circulation2009，，14： | 2 |
| 4 | Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction显示文摘 | Wang NC Maggioni AP Konstam MA | 2008 | JAMA2008，99，22： | 1 |
| 5 | Short-term clinical effects of tolvaptan,an oral vasopressin antagonist,in patients hospitalized for heart failure:the EVEREST Clinical Status Trials显示文摘 | Gheorghiade M Konstam M A Burnett J J | 2007 | JAMA2007，297，12： | 1 |
| 6 | Short term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials显示文摘 | Gheorghiade M Konstam MA Burnett JC Jr | 2007 | JAMA2007，297，12： | 1 |
| 7 | Effects of lasartan and captopril on left ventricular volumes in elderly patients with heart failure:results of the ELITE ventricular function substudy 显示文摘 | Konstam MA Patten RD Thomas I | 2000 | Am Heart J2000，139，： | 1 |
| 8 | Short term clinical effects of tolvaptan,an oral vasopressin antagonist,in patients hospitalized for heart failure: results of the EVEREST clinical status trials显示文摘 | Gheorghiade M Konstam MA Burnett JC | 2007 | JAMA2007，297，12： | 1 |
| 9 | Effects of oral tolvaptan in patients hospitalized for worsening heart {ailure: the EVEREST Outcome Trial显示文摘 | Gheorghiade M Konstam MA Burnett JC Jr | 2007 | JAMA2007，297，12： | 1 |
| 10 | Cardiovascular thrombotic events in controlled,clinical trial of rofecoxib显示文摘 | KONSTAM MA WEIR MR REICIN A | 2001 | Circulation2001，104，19： | 1 |
| 11 | Role of angiotensin converting enzyme inhibitors in preventing left ventricular remodeling following myocardial infarction显示文摘 | Konstam MA | | 0，，： | 1 |
| 12 | Acute Hemodynamic Effects of Conivaptan, a Dual V1A and V2 Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure显示文摘 | James E. Udelson William B. Smith Grady H. Hendrix Christopher A. Painchaud Maha Ghazzi Ignatius Thomas Jalal K. Ghali Paulina Selaru Francoise Chanoine Milton L. Pressler Marvin A. Konstam | 2001 | Circulation: Journal of the American Heart Association2001，，20： | 1 |
| 13 | Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure显示文摘 | BLAIR J ZANNAD F KONSTAM M | 2008 | J Am Coll Cardiol2008，52，20： | 1 |
| 14 | Short term clinical effects of tolvaptan,an oral vasopressin antagonist,in patients hospitalized for heart failure:the EVEREST clinical status trials显示文摘 | Gheorghiade M Konstam MA Burnett JC | 2007 | JAMA2007，，297： | 1 |
| 15 | Effects of tolvaptan on dyspnoea relief from the EVEREST trials显示文摘 | PANG P KONSTAM M KRASA H | 2009 | Eur Heart J2009，309，18： | 1 |
| 16 | Effects of oral tolvaptan in patients hospitalized for worsening heart failure:the EVEREST Outcome Trial显示文摘 | Konstam MA Gheorghiade M Burnett JC Jr | 2007 | JAMA2007，297，2： | 1 |
| 17 | Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators 显示文摘 | KONSTAM MA GHEORGHIADE M BURNETT JC | 2007 | JAMA2007，297，12： | 1 |
| 18 | Leftventricular remodeling in heart failure: current concepts inclinical significance and assessment显示文摘 | KONSTAM M A KRAMER D G PATEL A R | 2011 | JACC Cardiovasc Im-aging2011，4，1： | 1 |
| 19 | Thrombus imaging in a primate model with antibodies specific for an external membrane protein of activated platelets 显示文摘 | Balabrica TM Furie BC Konstam MA | 1989 | Proc Natl Acad Sci USA1989，86，： | 1 |
| 20 | Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment显示文摘 | Konstam MA Kramer DG Pate/ AR | 2011 | J Am Co]l Cardiol Cardiovasc Imaging2011，4，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员